RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PANNI S
Collezione AO Ordine Mauriziano

Items : 6

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.

2024
AO Ordine Mauriziano

Messina C; Catalano M; Roviello G; Gandini A; Maruzzo M; De Giorgi U; Pedrazzoli P; Sbrana A; Zucal PA; Masini C; Naglieri E; Procopio G; Milella M; Catalano F; Fratino L; Pipitone S; Ricotta R; Panni S; Mollica V; Soraru M; Prati V; Atzori F; Di Napoli M; Messina M; Morelli F; Prati G; Nole F; Malgeri A; Tudini M; et alii...

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study. in Journal of translational medicine / J Transl Med. 2022 Sep 30;20(1):435. doi: 10.1186/s12967-022-03601-6.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Messina M; Caffo O; Di Napoli M; Atzori F; Santini D; Soto Parra HJ; Prati V; Cortellini A; Santoni M; Sorarù M; Mollica V; Panni S; Ricotta R; Pipitone S; Fratino L; Boccardo F; Milella M; Procopio G; Naglieri E; Fantinel E; Zucali PA; Galli L; Chiellino S; Basso U; De Giorgi U; Maruzzo M; Damassi A; Fornarini G; Gandini A; et alii...

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The ?-Meet-URO analysis. in Frontiers in oncology / Front Oncol. 2022 Sep 23;12:955501. doi: 10.3389/fonc.2022.955501. eCollection 2022.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Nolè F; Prati G; Morelli F; Messina M; Caffo O; Di Napoli M; Atzori F; Soto Parra HJ; Prati V; Cortellini A; Sorarù M; Santoni M; Massari F; Panni S; Ricotta R; Sabbatini R; Fratino L; Boccardo F; Milella M; Procopio G; Carella C; Fantinel E; Zucali PA; Galli L; Pedrazzoli P; De Giorgi U; Maruzzo M; Santini D; Stellato M; et alii...

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano

Bersanelli M; Casadei C; Pierantoni F; Roviello G; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Messina C; Messina M; Pignata S; Atzori F; Stellato M; Soto Parra HJ; Prati V; Santoni M; Cortellini A; Sorarù M; Mollica V; Panni S; Ricotta R; Baldessari C; Fratino L; Tomasello L; Merler S; Procopio G; Naglieri E; Masini C; et alii...

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study. in Immunotherapy / Immunotherapy. 2020 Feb;12(2):151-159. doi: 10.2217/imt-2019-0180.

2020
AO Ordine Mauriziano

Bersanelli M; Buti S; Banna GL; De Giorgi U; Cortellini A; Rebuzzi SE; Tiseo M; Fornarini G; Mazzoni F; Panni S; De Tursi M; Di Marino P; Rossetti S; Rossi E; Tomao S; De Luca E; Sorarù M; Mucciarini C; Atzori F; La Torre L; Vitale MG; Martelli V; Sepe P; Mollica V; Vaccaro V; Schinzari G; Ficorella C; Massari F; Maestri A; et alii...

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. in Immunotherapy / Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.

2018
AO Ordine Mauriziano

Bersanelli M; Giannarelli D; Castrignanò P; Fornarini G; Panni S; Mazzoni F; Tiseo M; Rossetti S; Gambale E; Rossi E; Papa A; Cortellini A; Lolli C; Ratta R; Michiara M; Milella M; De Luca E; Sorarù M; Mucciarini C; Atzori F; Banna GL; La Torre L; Vitale MG; Massari F; Rebuzzi SE; Facchini G; Schinzari G; Tomao S; Bui S; et alii...